Bilaketaren emaitzak - Jan‐Willem C. Alffenaar

Findu emaitzak
  1. 1
    New Approaches and Therapeutic Options for Mycobacterium tuberculosis in a Dormant State

    New Approaches and Therapeutic Options for Mycobacterium tuberculosis in a Dormant State nork Santiago Caño-Muñiz, Richard Anthony, Stefan Niemann, Jan‐Willem C. Alffenaar

    Argitaratua 2017
    Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  2. 2
    Dried blood spot analysis of creatinine with LC-MS/MS in addition to immunosuppressants analysis

    Dried blood spot analysis of creatinine with LC-MS/MS in addition to immunosuppressants analysis nork Remco A. Koster, Ben Greijdanus, Jan‐Willem C. Alffenaar, Daan J. Touw

    Argitaratua 2014
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  3. 3
    Risk factors of multidrug-resistant tuberculosis: A global systematic review and meta-analysis

    Risk factors of multidrug-resistant tuberculosis: A global systematic review and meta-analysis nork Ivan Surya Pradipta, Lina Davies Forsman, Judith Bruchfeld, Eelko Hak, Jan‐Willem C. Alffenaar

    Argitaratua 2018
    Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  4. 4
    Therapeutic drug monitoring in patients with tuberculosis and concurrent medical problems

    Therapeutic drug monitoring in patients with tuberculosis and concurrent medical problems nork Anne‐Grete Märtson, Gena Burch, Samiksha Ghimire, Jan‐Willem C. Alffenaar, Charles A. Peloquin

    Argitaratua 2020
    Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  5. 5
    Factors influencing physicians’ antimicrobial prescribing decisions: A systematic review of qualitative studies

    Factors influencing physicians’ antimicrobial prescribing decisions: A systematic review of qualitative studies nork Savannah Reali, Yee Chin Kwang, Parisa Aslani, Jan‐Willem C. Alffenaar, Jin‐Gun Cho

    Argitaratua 2025
    Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  6. 6
    The Role of Fluoroquinolones in the Treatment of Tuberculosis in 2019

    The Role of Fluoroquinolones in the Treatment of Tuberculosis in 2019 nork Arianna D. Pranger, Tjip S. van der Werf, Jos G.W. Kosterink, Jan‐Willem C. Alffenaar

    Argitaratua 2019
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  7. 7
    Pharmacokinetic Drug Interactions of Antimicrobial Drugs: A Systematic Review on Oxazolidinones, Rifamycines, Macrolides, Fluoroquinolones, and Beta-Lactams

    Pharmacokinetic Drug Interactions of Antimicrobial Drugs: A Systematic Review on Oxazolidinones, Rifamycines, Macrolides, Fluoroquinolones, and Beta-Lactams nork Mathieu S. Bolhuis, Prashant Nannan Panday, Arianna D. Pranger, Jos G.W. Kosterink, Jan‐Willem C. Alffenaar

    Argitaratua 2011
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  8. 8
    Interventions to improve medication adherence in tuberculosis patients: a systematic review of randomized controlled studies

    Interventions to improve medication adherence in tuberculosis patients: a systematic review of randomized controlled studies nork Ivan Surya Pradipta, Daphne Houtsma, Job F. M. van Boven, Jan‐Willem C. Alffenaar, Eelko Hak

    Argitaratua 2020
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  9. 9
    A Volumetric Absorptive Microsampling LC–MS/MS Method for Five Immunosuppressants and Their Hematocrit Effects

    A Volumetric Absorptive Microsampling LC–MS/MS Method for Five Immunosuppressants and Their Hematocrit Effects nork Remco A. Koster, Pascal Niemeijer, Herman Veenhof, Kai van Hateren, Jan‐Willem C. Alffenaar, Daan J. Touw

    Argitaratua 2019
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  10. 10
    Alternative Sampling Devices to Collect Dried Blood Microsamples: State-of-the-Art

    Alternative Sampling Devices to Collect Dried Blood Microsamples: State-of-the-Art nork Lisa Delahaye, Herman Veenhof, Birgit C. P. Koch, Jan‐Willem C. Alffenaar, Rafael Linden, Christophe P. Stove

    Argitaratua 2021
    Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  11. 11
    Simultaneous Quantification of Levofloxacin and Linezolid in human Plasma and Saliva Using Liquid Chromatography Quadrupole‐Orbitrap Mass Spectrometry

    Simultaneous Quantification of Levofloxacin and Linezolid in human Plasma and Saliva Using Liquid Chromatography Quadrupole‐Orbitrap Mass Spectrometry nork Thi Anh Nguyen, Christa E. Nath, Sebastian P. A. Rosser, Sophie L. Stocker, Jan‐Willem C. Alffenaar

    Argitaratua 2025
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  12. 12
    Therapeutic drug monitoring: how to improve drug dosage and patient safety in tuberculosis treatment

    Therapeutic drug monitoring: how to improve drug dosage and patient safety in tuberculosis treatment nork Giovanni Sotgiu, Jan‐Willem C. Alffenaar, Rosella Centis, Lia D’Ambrosio, Antonio Spanevello, Andrea Piana, Giovanni Battista Migliori

    Argitaratua 2015
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  13. 13
    Global TB Network: working together to eliminate tuberculosis

    Global TB Network: working together to eliminate tuberculosis nork Denise Rossato Silva, Adrián Rendón, Jan‐Willem C. Alffenaar, Jeremiah Chakaya, Giovanni Sotgiu, Susanna Esposito, Giovanni Battista Migliori

    Argitaratua 2018
    Testu osoa Testu osoa
    Editorial
    Gogokoenen artean sartu
    Gorde:
  14. 14
    Determination of moxifloxacin in dried blood spots using LC–MS/MS and the impact of the hematocrit and blood volume

    Determination of moxifloxacin in dried blood spots using LC–MS/MS and the impact of the hematocrit and blood volume nork Dinh Hoa Vu, Remco A. Koster, Jan‐Willem C. Alffenaar, J. R. B. J. Brouwers, Donald R. A. Uges

    Argitaratua 2011
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  15. 15
    Influence of Inflammation on Voriconazole Metabolism

    Influence of Inflammation on Voriconazole Metabolism nork M Ventura, Lambert F. R. Span, Edwin R. van den Heuvel, Geny M. M. Groothuis, Jan‐Willem C. Alffenaar

    Argitaratua 2015
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  16. 16
    Clinical Validation of Simultaneous Analysis of Tacrolimus, Cyclosporine A, and Creatinine in Dried Blood Spots in Kidney Transplant Patients

    Clinical Validation of Simultaneous Analysis of Tacrolimus, Cyclosporine A, and Creatinine in Dried Blood Spots in Kidney Transplant Patients nork Herman Veenhof, Remco A. Koster, Jan‐Willem C. Alffenaar, Stefan P. Berger, Stephan J. L. Bakker, Daan J. Touw

    Argitaratua 2016
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  17. 17
    The association between the <i>NAT2</i> genetic polymorphisms and risk of DILI during anti‐TB treatment: a systematic review and meta‐analysis

    The association between the <i>NAT2</i> genetic polymorphisms and risk of DILI during anti‐TB treatment: a systematic review and meta‐analysis nork Min Zhang, Shuqiang Wang, Bob Wilffert, Rongsheng Tong, Dick van Soolingen, Susan van den Hof, Jan‐Willem C. Alffenaar

    Argitaratua 2018
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  18. 18
    Linezolid-based Regimens for Multidrug-resistant Tuberculosis (TB): A Systematic Review to Establish or Revise the Current Recommended Dose for TB Treatment

    Linezolid-based Regimens for Multidrug-resistant Tuberculosis (TB): A Systematic Review to Establish or Revise the Current Recommended Dose for TB Treatment nork Mathieu S. Bolhuis, Onno W. Akkerman, Marieke G. G. Sturkenboom, Samiksha Ghimire, Shashikant Srivastava, Tawanda Gumbo, Jan‐Willem C. Alffenaar

    Argitaratua 2018
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  19. 19
    Barriers and strategies to successful tuberculosis treatment in a high-burden tuberculosis setting: a qualitative study from the patient’s perspective

    Barriers and strategies to successful tuberculosis treatment in a high-burden tuberculosis setting: a qualitative study from the patient’s perspective nork Ivan Surya Pradipta, Lusiana R. Idrus, Ari Probandari, Bony Wiem Lestari, Ajeng Diantini, Jan‐Willem C. Alffenaar, Eelko Hak

    Argitaratua 2021
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  20. 20
    Bedaquiline Resistance: Its Emergence, Mechanism, and Prevention

    Bedaquiline Resistance: Its Emergence, Mechanism, and Prevention nork Thi Van Anh Nguyen, Richard Anthony, Anne‐Laure Bañuls, Thi Van Anh Nguyen, Dinh Hoa Vu, Jan‐Willem C. Alffenaar

    Argitaratua 2017
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:

Bilaketa egiteko lanabesak: